Enhancing Motivation in Recent Onset Schizophrenia



Status:Recruiting
Conditions:Schizophrenia
Therapuetic Areas:Psychiatry / Psychology
Healthy:No
Age Range:14 - 30
Updated:4/21/2016
Start Date:July 2014
End Date:April 2018

Use our guide to learn which trials are right for you!

Developing an Intervention Strategy to Enhance Motivation in Recent Onset Schizophrenia

This project will result in the development of a personalized intervention strategy to
improve motivation for treatment engagement and functional outcomes in individuals with a
recent onset of schizophrenia. Motivational impairment is arguably the single most important
factor that determines a patient's ability to engage in and adhere to effective treatment.
In our study, sixty participants will be enrolled in a randomized controlled trial comparing
the feasibility and tolerability of two types of motivational interventions (Daily Goals or
PRIME), and a neuroplasticity-based cognitive training program. Participants are randomized
to either receive Daily Goals or PRIME for 8 weeks, after which, both conditions will also
receive an 8-week course of cognitive training delivered via iPads. Participants will
undergo pre/post-testing and a 6-month follow-up to determine feasibility and efficacy of
the interventions. By enhancing motivation, schizophrenia patients would be able to engage
more fully with treatment and develop full and productive lives. This study may also pave
the way forward for other health conditions in which motivational impairments impede health
outcomes.

All assessments will be conducted at the University of California, San Francisco; however,
we offer some assessments to be done remotely.


Inclusion Criteria:

- Diagnosis of schizophrenia, schizoaffective, or schizophreniform disorder.

- Onset of diagnosis within 5 years.

- 14-30 years old.

- Clinically stable (outpatient status for 1 month and stable dose of medication for 1
month).

- Good general health

Exclusion Criteria:

- Substance dependence within the past 12 months,

- Current substance abuse,

- No history of neurological disorder
We found this trial at
1
site
San Francisco, California 94143
Principal Investigator: Danielle A Schlosser, PhD
Phone: 415-476-7144
?
mi
from
San Francisco, CA
Click here to add this to my saved trials